On the origin of relapse in AML

Sci Transl Med. 2017 Jul 12;9(398):eaan8205. doi: 10.1126/scitranslmed.aan8205.

Author

Brian A Jonas¹

Affiliation

¹ Department of Internal Medicine, University of California, Davis, Sacramento, CA 95817, USA. Email: bajonas@ucdavis.edu.

Abstract

Preexisting therapy-resistant leukemia stem cell populations underlie the cellular origin of relapse in acute myeloid leukemia.

Copyright © 2017, American Association for the Advancement of Science.

Publication types

Comment

MeSH terms

Humans
Leukemia, Myeloid, Acute*
Recurrence
Stem Cells

Grants and funding